Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics
Christian BorkDepartment of Cardiology, Aalborg University Hospital, Gistrup, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address: [email protected]Børge G. NordestgaardDepartment of Cardiology, Aalborg University Hospital, Gistrup, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address: [email protected]Berit Storgaard HedegaardDepartment of Clinical Biochemistry, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Electronic address: [email protected]Michal VrablikDepartment of Clinical Biochemistry, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Electronic address: [email protected]Elsie EvansDepartment of Cardiology, Regional Hospital Central Jutland, Viborg, DenmarkTomáš Freiberger3rd Department of Internal Medicine, 1st Medical Faculty, Charles University, General University Hospital, Prague, Czech RepublicZlatko FrasFH Europe Foundation, Amsterdam, the NetherlandsDavid NanchenCentre of Cardiovascular Surgery and Transplantation Brno, and Medical Faculty, Masaryk University, Brno, Czech RepublicFouzia SadiqCentre for Preventive Cardiology, Department of Vascular Medicine, Divison of Medicine, University Medical Centre Ljubljana, 1525, Ljubljana, Slovenia; Medical Faculty, University of Ljubljana, 1000, Ljubljana, SloveniaKausik K. RayCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, SwitzerlandKirsten B. HolvenDirectorate of Research, Shifa Tameer-e-Millat University, Islamabad, PakistanJeanine E. Roeters van LennepDepartment of Primary Care and Public Health, Imperial College London, Wood Lane, London, UKUlrich LaufsDepartment of Nutrition, Medical Faculty, University of Oslo, Oslo, Norway; National Quality Network on FH, Oslo University Hospital, Oslo, NorwayMarianne BennDepartment of Internal Medicine, Cardiovascular Institute, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the NetherlandsShoaib AfzalKlinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, 04103, Leipzig, GermanyEvangelos LiberopoulosDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Copenhagen University Hospital - Rigshospitalet, Copenhagen Ø, DenmarkKatariina ÖörniDepartment of Clinical Biochemistry, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkMeral KayikciogluFirst Department of Propaedeutic and Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, GreeceMutaz Al-KhnifsawiMolecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Finland; Wihuri Research Institute, Helsinki, FinlandKhalid Al-RasadiDepartment of Cardiology, Ege University Medical School Izmir, TurkeyLambert Tetteh AppiahCollege of Pharmacy, University of Al-Qadisiyah, Diwaniya, IraqMakhabbat BekbossynovaDepartment of Biochemistry, College of Medicine & Health Sciences, Medical Research Center, Sultan Qaboos University, Muscat, OmanMarianne BeckerDepartment of Medicine, Cardiology Unit, Kwame Nkrumah University of Science & Technology, Komfo Anokye Teaching Hospital, Kumasi, GhanaChristoph J. BinderHeart Center, Corporate Fund, University Medical Center, Astana, KazakhstanMáxima Méndez CastilloDepartment of Pediatric Endocrinology and Diabetology, Centre hospitalier de Luxembourg, LuxembourgMariia CherskaDepartment of Laboratory Medicine, Medical University of Vienna, Vienna, AustriaKrzysztof ChlebusClínica de Lípidos (Cli-LIPID) and Cardiometabolic Prevention Unit, Santo Domingo, Dominican RepublicPablo CorralCardiology Department, Institute of Endocrinology and Metabolism, Kyiv, UkraineR.Y. Durst1st Department of Cardiology Medical University of Gdansk, National Centre of Familial Hypercholesterolaemia, University Clinical Center, Gdańsk, PolandMarat EzhovFASTA University, Pharmacology and Research Department, Instituto Investigaciones Clínicas (IIC), Mar del Plata, ArgentinaDan GaitaCardiology Department, Hadassah Hebrew University Medical Center Jerusalem, IsraelFederica GalimbertiNational Medical Research Center of Cardiology n.a. acad. E.I. Chazov, Ministry of Health of the Russian Federation, Moscow, RussiaDaniel GaudetInstitute of Cardiovascular Diseases, University of Medicine and Pharmacy Victor Babes, Research Center IBCVTIM, Timisoara, RomaniaTea GamezardashviliIRCCS MultiMedica, Sesto San Giovanni, Milan, ItalyÁngel A. García-PeñaDepartment of Medicine, Université de Montréal and Ecogene-21, CanadaUrh GrošeljThe Georgian Atherosclerosis Society, GeorgiaMariko Harada-ShibaDepartment of Cardiology, Hospital Universitario San Ignacio, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, ColombiaSergio Emmanuel KaiserUniversity Children's Hospital, Ljubljana University Medical Center, Ljubljana, SloveniaGustavs LatkovskisCardiovascular Center, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, JapanVincent MaherDiscipline of Clinical and Experimental Pathophysiology, Rio de Janeiro State University, Rio de Janeiro, BrazilWinfried MärzFaculty of Medicine and Life Sciences, University of Latvia, Riga, Latvia; Latvian Center of Cardiology, Pauls Stradins Clinical University Hospital, Riga, LatviaL. MasanaTallaght University Hospital, Tallaght, Dublin, Ireland; Trinity College Dublin, IrelandAnne Thushara MatthiasDepartment of Medicine III (Cardiology, Pneumonology, Angiology), Medical Faculty Heidelberg, University of Heidelberg, Germany; Synlab Academy, SYNLAB Holding Deutschland GmbH, Mannheim, Germany; Department of Medicine, Medical University of Graz, Graz, AustriaA. MertensUniversitat Rovira i Virgili, Lipid RDI Cluster (LIRIC), IRB CatSud, CIBERDEM, Reus, SpainOlena MitchenkoFaculty of Medical Sciences, University of Sri Jayewardenepura, Sri LankaAdam J. NelsonDepartment of Endocrinology, University Hospitals Leuven, Leuven, BelgiumStephen J. NichollsDepartment of Endocrine Cardiology and Dyslipidemias, National Scientific Center, The M.D. Strazhesko Institute of Cardiology, Clinical and Regenerative Medicine, The National Academy of Medical Sciences, UkraineRichard C. O’BrienDepartment of Medicine, Adelaide University, South Australia, Australia; Department of Cardiology, Royal Adelaide Hospital, Adelaide, South Australia, AustraliaBelma PojskicVictorian Heart Institute, Monash University, Clayton, VIC, AustraliaGyörgy ParaghMelbourne Medical School, University of Melbourne, Parkville, Australia; Austin Health, Heidelberg, AustraliaZaneta PetrulionieneMedical Faculty of University Zenica, Bosnia and HerzegovinaArman PostadzhiyanDivision of Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032, Debrecen, HungaryFrederick J. RaalInstitute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius University Hospital Santaros Klinikos, Republic of LithuaniaAshraf RedaMedical University of Sofia, Sofia, Bulgaria; Department of Cardiology, Saint Anna University Hospital, Sofia, BulgariaXimena ReyesCarbohydrate and Lipid Metabolism Research Unit, Department of Medicine, University of the Witwatersrand, Johannesburg, South AfricaŽeljko ReinerCardiology Department, Menoufia University, EgyptStefano RomeoLipid Disorders Clinic, Department of Cardiology, Hospital Evangélico, Montevideo, Uruguay; GENYCO Program, Cardiovascular Genetics Area, Honorary Commission for Cardiovascular Health, Montevideo, UruguayCarlos A Aguilar SalinasDepartment for Internal Diseases University Hospital Center Zagreb, Zagreb, CroatiaErik S. StroesInstitute of Medicine, Centre for Reproduction, Metabolism and Molecular Medicine (CeRM), Karolinska Institute, Huddinge, Sweden; Department of Endocrinology, Karolinska University Hospital, Huddinge, SwedenPhivos SymeonidesInstituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Ave. Morones Prieto 3000, Monterrey, N.L., MéxicoAleksandr B. ShekDepartment of Vascular Medicine, Amsterdam UMC, location AMC, Amsterdam, the NetherlandsAlberto Mello e SilvaHippocrateon Private Hospital, CyprusTigist MekonnenDepartment of Ischemic Heart Disease and Atherosclerosis, Republican Specialized Scientific and Practical Medical Center of Cardiology, Tashkent, UzbekistanMyra TilneySociedade Portuguesa de Aterosclerose, Department of Cardiology, Luz-Saúde, Lisboa, PortugalLale TokgozogluDepartment of Cardiology, College of Health Sciences, Addis Ababa University, Addis Ababa, EthiopiaAlexandros D. TselepisLipid Clinic, Mater Dei Hospital, Malta; Department of Medicine, Medical School, University of Malta, MaltaMargus ViigimaaDepartment of Cardiology, Hacettepe University, Ankara, TurkeyBranislav VohnoutAtherothrombosis Research Centre, University of Ioannina, Ioannina, GreeceLuz C. Zárate-CorreaNorth Estonia Medical Centre, Tallinn University of Technology, Tallinn, EstoniaPhilippe MoulinInstitute of Nutrition, FOaZOS, Department of Diabetology, Medical Faculty, Coordination Center for Familial Hyperlipoproteinemias, Slovak Medical University in Bratislava, Bratislava, Slovakia
ABI
Аннотация
Because one in three of all individuals die from atherosclerotic cardiovascular disease (ASCVD), prevention of ASCVD is key to public health worldwide. Lipid clinics provide specialized diagnostic assessment, lifestyle management, and evidence-based lipid-lowering treatment to prevent ASCVD and acute pancreatitis in high-risk individuals. This includes individuals with familial hypercholesterolemia and/or markedly increased lipoprotein(a), statin intolerance, refractory or difficult-to-control low-density lipoprotein (LDL) cholesterol, severe hypertriglyceridaemia, and other rare or complex lipid disorders. Such specialized care not only benefits the individual patients and their families but facilitates dissemination of best practices in lipid disorder management to healthcare professionals in individual nations. Despite this, there is a lack of guidance on standards and metrics needed to establish a well-harmonized national lipid clinic network in most countries capable of offering comprehensive care. This consensus paper from the European Atherosclerosis Society Lipid Clinic Network aims to meet this unmet clinical need. We provide recommendations to enhance education and training on lipid disorders and to harmonize lipid clinics at both national and international levels. Furthermore, we provide guidance on optimal staffing structures and development of registries to improve diagnosis and management of lipid disorders. Finally, we offer recommendations to national and regional policymakers on funding of lipid clinics, with the long-term goal of reducing the overall societal burden and costs of cardiovascular and other lipid-related diseases.
Ҳали таржима қилинмаган
Мавзулар
Идентификаторлар
Иқтибослар ва манбалар
0 та иқтибос72 та фойдаланилган манба